These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 26556567)
1. Predictors of response to renal denervation for resistant arterial hypertension: a single center experience. Rohla M; Nahler A; Lambert T; Reiter C; Gammer V; Grund M; Blessberger H; Kammler J; Kypta A; Saleh K; Huber K; Steinwender C; Weiss TW J Hypertens; 2016 Jan; 34(1):123-9. PubMed ID: 26556567 [TBL] [Abstract][Full Text] [Related]
2. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171 [TBL] [Abstract][Full Text] [Related]
3. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience. Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700 [TBL] [Abstract][Full Text] [Related]
4. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial. Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441 [TBL] [Abstract][Full Text] [Related]
5. Renal denervation in moderate treatment-resistant hypertension. Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901 [TBL] [Abstract][Full Text] [Related]
6. The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence. Ott C; Mahfoud F; Schmid A; Ewen S; Toennes SW; Meyer MR; Helfer AG; Maurer HH; Ditting T; Veelken R; Zivanovic I; Uder M; Böhm M; Schmieder RE J Hypertens; 2016 Dec; 34(12):2475-2479. PubMed ID: 27607458 [TBL] [Abstract][Full Text] [Related]
7. Renal denervation in hypertensive patients not on blood pressure lowering drugs. De Jager RL; Sanders MF; Bots ML; Lobo MD; Ewen S; Beeftink MM; Böhm M; Daemen J; Dörr O; Hering D; Mahfoud F; Nef H; Ott C; Saxena M; Schmieder RE; Schlaich MP; Spiering W; Tonino PA; Verloop WL; Vink EE; Vonken EJ; Voskuil M; Worthley SG; Blankestijn PJ Clin Res Cardiol; 2016 Sep; 105(9):755-62. PubMed ID: 27105858 [TBL] [Abstract][Full Text] [Related]
8. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305 [TBL] [Abstract][Full Text] [Related]
9. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels. Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366 [TBL] [Abstract][Full Text] [Related]
10. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension. Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527 [TBL] [Abstract][Full Text] [Related]